CORONIS 6.25mg Price

Overview

Welcome to Dwaey, specifically on CORONIS 6.25mg Tablets page.
This medicine contains an important and useful components, as it consists of Carvedilol.
CORONIS 6.25mg is available in the market in concentration 6.25mg/Tablet and in the form of Tablets.

BILIM PHARMACEUTICALS is the producer of CORONIS 6.25mg and it is imported from TURKEY, The most popular alternatives of CORONIS 6.25mg are listed downward .

Mode Of Action

Carvedilol is a nonselective beta-adrenoreceptor and alpha-adrenergic blocking activity. It exerts antihypertensive effect partly by reducing total peripheral resistance and vasodilation.

Indication

• Hypertension
• Congestive heart failure
• Myocardial infarction
• Left ventricular dysfunction
• Angina pectoris

Precaution

Avoid abrupt withdrawal as it may precipitate thyroid storm or exacerbate hyperthyroidism. Liver injury; vascular disease, renal failures, suspected phaeochromocytoma and prinzmetal's variable angina; worsening cardiac failure or fluid retention during increase in dosage of carvedilol; diabetic patients. Pregnancy. Lactation: Unknown whether drug is excreted in milk; not recommended

Side Effects

• >10% Dizziness (2-32%)
• Fatigue (4-24%)
• Hypotension (9-20%)
• Weight gain (10-12%)
• Hyperglycemia (5-12%)
• Diarrhea (1-12%) 1-10% Bradycardia (2-10%)
• Nausea (2-9%)
• Cough (5-8%)
• Headache (5-8%)
• Atrioventricular block
• edema (1-7%)
• Angina (1-6%)
• Hpercholesterolemia (1-4%)
• Hypertriglyceredemia (1%)
• Vomiting (1-6%)
• Dyspnea (>3%)
• Syncope (3%)
• Rhinitis (2%) Frequency Not Defined Hypertension
• Palpitations
• Insomnia
• Somnolence
• Skin rash
• Hepatotoxicity
• Impotence
• Bronchospasm
• Rales
• Depression
• Decreased exercise tolerance
• Raynaud phenomenon
• Increased triglyceride levels and insulin resistance with decreased high-density lipoprotein (HDL) levels

Contra indication

Hypersensitivity; severe chronic heart failure, bronchial asthma or related bronchospastic conditions; severe hepatic impairment. Patients with NYHA class IV cardiac failure, 2nd or 3rd ° AV block, sick sinus syndrome (unless a permanent pacemaker is in place), cardiogenic shock or severe bradycardia. Lactation.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Pregnancy category: C; D in 2nd and 3rd trimesters